Follicular Variant Papillary Thyroid Carcinoma Arising in Struma Ovarii
- 9 August 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine Pathology
- Vol. 18 (3), 182-186
- https://doi.org/10.1007/s12022-007-0022-8
Abstract
Struma ovarii is a rare monodermal ovarian teratoma in which thyroid tissue is the predominant or exclusive element. Malignant transformation is known to occur, usually as classical papillary thyroid carcinoma (PTC). However, the recognition of follicular variant PTC raises the possibility of similar malignancy arising in struma ovarii. We examined 13 cases of struma ovarii to determine if these lesions can exhibit histological, immunohistochemical, and/or molecular features of follicular variant PTC. Ten of these had atypical histology, cytologic features of PTC, and all ten showed diffuse positivity for CK19; eight of these were also positive for HMBE-1. Mutational analysis for BRAF identified no V600E mutations. However, seven of the ten cases with features of follicular variant PTC exhibited a rearranged in transformation (RET)/PTC rearrangement by reverse transcriptase polymerase chain reaction (RT-PCR). The three cases considered to be benign based on histologic and cytologic criteria were negative for CK19 and HBME-1 by immunohistochemistry, and had no evidence of BRAF mutation or ret/PTC-1 and ret/PTC-3 rearrangements. These results indicate that follicular variant PTC can occur in struma ovarii and that such lesions exhibit the same morphologic and immunohistochemical profile as follicular variant PTC in thyroid. The application of molecular testing to verify the diagnosis can be valuable, as these lesions may harbor ret/PTC gene rearrangements.This publication has 20 references indexed in Scilit:
- BRAF T1799A Mutation Occurring in a Case of Malignant Struma OvariiInternational Journal of Surgical Pathology, 2007
- The enigma of struma ovariiPathology, 2007
- Metastatic Struma Ovarii: The Burden of TruthClinical Nuclear Medicine, 2006
- Pathogenetic mechanisms in thyroid follicular-cell neoplasiaNature Reviews Cancer, 2006
- RET/PTC3 Rearrangement and Thyroid Differentiation Gene Analysis in a Struma Ovarii Fortuitously Revealed by Elevated Serum Thyroglobulin ConcentrationThyroid®, 2005
- The Use of a Combination of Galectin-3 and Thyroid Peroxidase for the Diagnosis and Prognosis of Thyroid CancerAmerican Journal of Clinical Pathology, 2004
- The Use of a Combination of Galectin-3 and Thyroid Peroxidase for the Diagnosis and Prognosis of Thyroid CancerAmerican Journal of Clinical Pathology, 2004
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Proliferative and Histologically Malignant Struma OvariiInternational Journal of Gynecological Pathology, 1993
- Malignant struma ovariiGynecologic Oncology, 1989